|
FAM3D expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.267800E-02 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.342000E-01 |
| Normal-vs-Stage2 |
2.231600E-02 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.608800E-01 |
| Stage1-vs-Stage2 |
1.662430E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
9.861400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
2.977000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.414100E-02 |
| Normal-vs-AfricanAmerican |
5.010200E-01 |
| Normal-vs-Asian |
2.160200E-01 |
| Caucasian-vs-AfricanAmerican |
8.134600E-01 |
| Caucasian-vs-Asian |
2.828800E-01 |
| AfricanAmerican-vs-Asian |
5.851600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.996100E-02 |
| Normal-vs-Female |
1.186640E-01 |
| Male-vs-Female |
2.828200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.801550E-02 |
| Normal-vs-Extreme_Weight |
1.172960E-01 |
| Normal-vs-Obese |
1.667970E-01 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
1.735790E-01 |
| Normal_Weight-vs-Obese |
2.561400E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
7.534800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.877800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.947430E-01 |
| Normal-vs-Age(61-80Yrs) |
1.172020E-01 |
| Normal-vs-Age(81-100Yrs) |
N/A |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.204390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.532800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
N/A |
| Normal-vs-Grade 3 |
N/A |
| Normal-vs-Grade 4 |
N/A |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.984000E-01 |
| Grade 2-vs-Grade 4 |
N/A |
| Grade 3-vs-Grade 4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.289350E-01 |
| Normal-vs-N1 |
2.741200E-01 |
| N0-vs-N1 |
5.928800E-01 |
|
|
